Comments on: "Synergistic activity of mTORC1/2 kinase and MEK inhibitors suppresses pediatric low-grade glioma tumorigenicity and vascularity".
Olaf van Tellingen
,
Mark C de Gooijer
,
Jann N Sarkaria
,
William F Elmquist
More about this publication
Neuro-oncology
Volume
22
Issue nr.
9
Pages
1404-1405
Publication date
29-09-2020
Full text links
Publisher website (DOI)
10.1093/neuonc/noaa112
Europe PubMed Central
32556220
Pubmed
32556220